Development of dominant epitope-based vaccines encoding Gp63, Kmp-11 and Amastin against visceral leishmaniasis
| Autor: | Qiwei Chen, Dali Chen, Jiao Li, Jinlei He, Hanxiao Qin, Zhiwan Zheng, Qi Zhou, Jian-Ping Chen, Han Chen, Xuechun Liao, Chang Liang, Yuying Xiao, Jianhui Zhang |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
0301 basic medicine
Immunology Protozoan Proteins Antibodies Protozoan Enzyme-Linked Immunosorbent Assay Biology Epitope 03 medical and health sciences Epitopes Mice 0302 clinical medicine Immune system Antigen T-Lymphocyte Subsets Cricetinae medicine Immunology and Allergy Animals Leishmania infantum Leishmaniasis Vaccines Metalloendopeptidases Leishmaniasis Hematology medicine.disease Leishmania biology.organism_classification Virology Recombinant Proteins Vaccination Disease Models Animal 030104 developmental biology Visceral leishmaniasis Immunoglobulin G Cytokines Leishmaniasis Visceral Female Immunization Spleen 030215 immunology |
| Zdroj: | Immunobiology. 226(3) |
| ISSN: | 1878-3279 |
| Popis: | The most dangerous form of leishmaniasis is Visceral leishmaniasis (VL). The elimination of VL depends not only on agent treatments but also on effective vaccines against Leishmania parasites. Epitope-based vaccines composed of alternative short antigenic epitopes have the advantages of MHC epitope easy designing, which has broad application prospects. In a previous study, we analyzed Leishmania Gp63, Kmp-11 and Amastin protein sequence in silico, and found that the amino acid fragments of Gp63 (138-360aa), Kmp-11 (1-91aa) and Amastin (1-72aa) were rich in dominant epitopes. In this study, we used the three amino acid fragments as multi-epitope vaccine candidates to construct DNA and protein vaccines. BALB/c mice were vaccinated with the DNA and protein vaccines by DNA prime-protein boost strategy and challenged with Leishmania promastigotes. To evaluate vaccine immunogenicity and immunoprotection, serum specific antibody titers and cytokines were detected using ELISA, splenic CD3+, CD4+ and CD8+ cells were analyzed by flow cytometry, livers were made into pathological sections to observe pathological changes, and splenic parasitic loads were quantified using qPCR. The results showed that the increased specific IgG titers from vaccinated mice supported the vaccine immunogenicity. The increased cytokines (IFN-γ, IL-12 and TNF-α), splenic CD3+, CD4+ and CD8+ T cells and hepatic granulomas, and the decreased splenic parasitic loads (parasite reduction rates of Gp63, Kmp-11 and Amatin groups were 89%, 86% and 79%, respectively) from immunized mice post-infection were suggested the good immunoprotection of the vaccines. Our study demonstrated that vaccines based on the dominant epitopes of Gp63, Kmp-11 and Amastin with DNA prime-protein boost vaccination strategy showed significant immune effects against Leishmania, especially the Gp63 group showed a nearly 90% parasites reduction rate. This study will provide references for visceral leishmaniasis epitope vaccine design and immune strategy selection. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect